Skip to main content
Clinical Trials/NCT03278860
NCT03278860UnknownNot Applicable

The Effects of Intranasal Oxytocin on Social Touch: an fMRI-based Study

University of Electronic Science and Technology of China1 site in 1 country50 target enrollmentStarted: August 28, 2017Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Neural indices: fMRI-based measures of interoceptive and reward processing

Study Overview

Brief Summary

The main aim of the study is to investigate whether intranasal oxytocin (24IU) can enhance hedonic experience and associated brain-reward reward responses to social touch.

Detailed Description

A double-blind, within-subject, placebo controlled design is employed in this study. In total 50 healthy male subjects will be recruited and they will come twice, once with the administration of oxytocin nasal spray and the other placebo (interval time is more than 2 weeks). 45 minutes after treatment subjects will be applied two different types of pleasant touch: social touch from a masseur (professional therapist) and non-social touch from a massage device. After each condition the subjects will be asked to rate pleasantness, likability, and arousal. Simultaneously functional brain activity will be acquired via fMRI. Blood samples will be taken before and after the intervention to assess oxytocin levels. All subjects were asked to complete a range of questionnaires measuring trait personality and mood: Beck Depression Inventory (BDI), Cheek and Buss Shyness Scale (CBSS),Autism Spectrum Quotient (ASQ), Empathy Quotient (EQ), NEO Five Factor Inventory (NEO-FFI), Liebowitz Social Anxiety Scale (LSAS),Behavioral Inhibition System and Behavioral Activation System Scale (BISBAS),Sensitivity to Punishment and Sensitivity to Reward Questionnaire (SPSRQ),State-Trait Anxiety Inventory (STAI), Social Touch Questionnaire (STQ), Sensory over Responsivity Scale (SOR) and Under Responsivity Scale (URS) one day before the first scanning. On the first and second scanning day, the subjects were asked to complete Positive and Negative Affect Schedule (PANAS) before and after treatment administration.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Healthy subjects without any past or present psychiatric or neurological disorders

Exclusion Criteria

  • History of brain injury
  • Medical or mental illness

Arms & Interventions

Oxytocin then placebo

Experimental

Participants first received oxytocin (24 IU). After a washout period of 2 weeks, they then received placebo (24 IU).

Intervention: intranasal oxytocin (Drug)

Oxytocin then placebo

Experimental

Participants first received oxytocin (24 IU). After a washout period of 2 weeks, they then received placebo (24 IU).

Intervention: intranasal placebo (Drug)

Placebo then oxytocin

Experimental

Participants first received placebo (24 IU). After a washout period of 2 weeks, they then received oxytocin (24 IU).

Intervention: intranasal oxytocin (Drug)

Placebo then oxytocin

Experimental

Participants first received placebo (24 IU). After a washout period of 2 weeks, they then received oxytocin (24 IU).

Intervention: intranasal placebo (Drug)

Outcomes

Primary Outcomes

Neural indices: fMRI-based measures of interoceptive and reward processing

Time Frame: 45-90 minutes after treatment administration

fMRI-based measures of social and non-social touch-related brain activity

Secondary Outcomes

  • Behavioral index: pleasantness experience(45-90 minutes after treatment administration)
  • Behavioral index: likability experience(45-90 minutes after treatment administration)
  • Behavioral index: arousal experience(45-90 minutes after treatment administration)

Investigators

Sponsor
University of Electronic Science and Technology of China
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Keith Kendrick

Professor

University of Electronic Science and Technology of China

Study Sites (1)

Loading locations...

Similar Trials

The Effects of Oxytocin on Social Touch | Clinical Trial